1. Article | 2020.06.16

   The use of Artificial Intelligence Methods to Discriminate Covid-19 from other Community Acquired Pneumopathy using Chest X-Ray and CT images

   Aim: Diagnostic of SARS-CoV-2 Coronavirus caused-disease (Covid-19) is a bottleneck in the immediate follow-up of patients. We propose automated detection methods based on Artificial Intelligence (AI) Algorithms (Machine Learning and Form Recognition), on chest Computed tomography (CT) or X-Ray images, to discriminate the Covid-19 disease from other Community Acquired Pneumonia (CAP). The methods...

2. Document de presse | 2020.11.03

   Number of Covid-19 deaths in the under-65s: a more reliable indicator for assessing infection rates in populations

   Simply comparing the total number of deaths across countries may provide a misleading representation of the underlying level of transmission of SARS-CoV-2, the virus that causes COVID-19, because of large differences in reported COVID-19 death rates in elderly populations in different countries.The research conducted by the University of Cambridge, the Institut Pasteur and the CNRS, published...

3. Document de presse | 2021.12.10

   COVID-19 patients in ICUs: Study reveals an increased risk of invasive fungal secondary infections

   What if certain fungi exacerbate respiratory distress in individuals with covid-19? The mycovid study published in the lancet respiratory medicine yields its initial results. Teams at Rennes University Hospital – University of Rennes 1, Necker-Enfants Malades Hospital (part of the Paris Public Hospital Network or AP-HP), Georges-Pompidou European Hospital (AP-HP) – Université de Paris, Avicenne...

4. Article | 2020.06.22

   Sequence the complete genome of Covid-19 directly and at low cost from prepared RNA samples from patients

   Aim: to be able to sequence the complete genome of Covid-19 directly and at low cost from prepared RNA samples from patients. We plan to implement a capture sequencing protocol targeting the SARS-CoV-2 genome using three commercial sets of probes in parallel. Results will be compared with a bioinformatics analysis pipeline and shared via publication (Biorxiv preprint followed by classical...

5. News | 2021.11.10

   COVID-19: Kamala Harris, Vice President of the United States, salutes the Institut Pasteur's response in tackling the pandemic

   As part of her trip to France for the fourth Paris Peace Forum – which includes three round tables on the challenges raised by the COVID-19 pandemic –, Kamala Harris, Vice President of the United States, visited the Institut Pasteur on November 9, 2021. She met several of the Institut Pasteur's scientists and saluted the unprecedented response of the Institut Pasteur's scientific community in...

6. News | 2020.12.07

   Unprecedented solidarity and support to accompany the member institutes of the International Network in the face of the COVID-19 pandemic

   The Institut Pasteur International Network, with the support of the International Department of the Institut Pasteur (Paris) and in association with institutional funders, has mobilised to help certain member institutes in Africa and Asia to carry out their public health missions in the context of the management of the COVID-19 pandemic.  The objective of this aid was to provide them with...

7. News | 2021.03.30

   Mobilization of the Institut Pasteur International Network to manage the COVID-19 outbreak: case study of support provided to the Institut Pasteur de Bangui

   Since the beginning of the COVID-19 pandemic, and increasingly rapidly thereafter, the Institut Pasteur International Network has drawn heavily on all its expertise and resources to tackle this emerging virus and its consequences, particularly through its support of institutes based in low-income countries. All Network member institutes have been identified by their health authorities as...

8. News | 2021.07.19

   COVID-19: interaction identified between SARS-CoV-2 and unusual RNA structures in human cells

   Replication of SARS-CoV-2, the virus responsible for COVID-19, depends on a series of interactions between viral proteins and different cellular partners such as nucleic acids (DNA or RNA). Characterizing these interactions is crucial to elucidate the process of viral replication and identify new drugs for treating COVID-19.An interdisciplinary consortium of scientists from the Institut Pasteur,...

9. News | 2021.08.13

   Low number of COVID-19 cases in Lao PTR: a seroprevalence study to confirm this figure

   In 2020 when many countries around the world struggled with a large burden of COVID-19 cases, the Lao PDR stood out as a country with low reported numbers of SARS-CoV-2 infections. Was it due to a low circulation of the virus or to an inadequate surveillance system? To answer this question, a seroprevalence study has been conducted by Institut Pasteur du Laos, in collaboration with Institut...

10. Document de presse | 2020.04.30

    Revealing how SARS-CoV-2 hijacks human cells; points to drugs with potential to fight COVID-19 and a drug that aids its infectious growth

    An international effort including researchers from University of California San Francisco (UCSF), Gladstone Institutes, Icahn School of Medicine at Mount Sinai and Institut Pasteur (Paris) unveils promising compounds for clinical testing against COVID-19. The study, led by UCSF Quantitative Biosciences Institute Director, Nevan Krogan, PhD, reveals that some drugs may fight COVID-19...

Pages